Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 February 2002

Cytomegalovirus infection and atherogenesis.

Andrzej Szkaradkiewicz, Joanna Bogaczyńska-Staniewicz, Lech Torliński, Marzena Wal

Med Sci Monit 2002; 8(2): CR104-107 :: ID: 420932

Abstract

BACKGROUND: Experimental studies and clinical observations indicate theimportance of active CMV infection in the development of atherosclerosis. Our research constituted anattempt to evaluate the components of lipid metabolism (total cholesterol and its fractions, triglycerides)in children with active CMV infection. MATERIAL/METHODS: The research involved 45 children with activeprimary or secondary CMV infection. The diagnosis was established by measuring anti-CMV serum antibodies(IgM and IgG) using the Enzyme-Linked Fluorescent Assay (ELFA) technique, and by detecting CMV-DNA usingthe PCR technique. On the basis of diagnostic tests, the children were allocated to one of two groups.The first group of 15 children manifested primary active infection with CMV. The other group consistedof 30 children diagnosed with secondary active CMV infection. RESULTS: In the first group, the mean valuesof the serum lipid profile were as follows: total cholesterol--142 +/- 32.9 mg/dl; HDL-cholesterol:--23.4 +/- 8.6 mg/dl; LDL-cholesterol--97.8 +/- 30.9 mg/dl; triglycerides--83 +/- 15.5 mg/dl. In the secondgroup of children, the mean values of serum lipid profile were as follows: total cholesterol-- 142.5+/- 44.2 mg/dl; HDL-cholesterol--21.4 +/- 10.8 mg/dl, LDL-cholesterol--87.1 +/- 35.3 mg/dl; triglycerides--101.7+/- 31.2 mg/dl. In all these children, the values of total cholesterol, LDL-cholesterol, and triglyceridesconformed to published norms, while HDL-cholesterol was significantly below normal. CONCLUSIONS: Theresults we obtained point to dyslipidemia in the course of active CMV infection, which may be of pathogeneticsignificance at any stage of atherogenesis.

Keywords: Arteriosclerosis, Child, Child, Preschool, Cholesterol, Triglycerides

Add Comment 0 Comments

Editorial

01 October 2024 : Editorial  

Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of Obesity

Dinah V. Parums

DOI: 10.12659/MSM.946675

Med Sci Monit 2024; 30:e946675

0:00

In Press

Clinical Research  

Evaluation of Neuromuscular Blockade: A Comparative Study of TOF-Cuff® on the Lower Leg and TOF-Scan® on th...

Med Sci Monit In Press; DOI: 10.12659/MSM.945227  

Clinical Research  

Acupuncture Enhances Quality of Life and Disease Control in Chronic Spontaneous Urticaria Patients on Omali...

Med Sci Monit In Press; DOI:  

Review article  

Sex and Population Variations in Nasopalatine Canal Dimensions: A CBCT-Based Systematic Review

Med Sci Monit In Press; DOI:  

Clinical Research  

Cold Pressor Test Induces Significant Changes in Internal Jugular Vein Flow Dynamics in Healthy Young Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.946055  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,057,271

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,850,733

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   693,892

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

07 Jan 2022 : Meta-Analysis   258,171

Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...

DOI :10.12659/MSM.935074

Med Sci Monit 2022; 28:e935074

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750